Literature DB >> 32295322

[Clinical analysis of 150 cases of 2019 novel coronavirus infection in Nanyang City, Henan Province].

C Sun1, X B Zhang1, Y Dai1, X Z Xu1, J Zhao1.   

Abstract

Objective: To analyze the epidemiological characteristics and clinical features of the patients with 2019-nCoV infection in Nanyang City, so as to provide evidence for clinical diagnosis and treatment.
Methods: The epidemiology, clinical symptoms, atory and radiologic data of 150 patients with 2019-nCoV infection admitted to the designated hospitals in Nanyang City from January 24,2020 to February 16, 2020 were retrospectively analyzed.
Results: The 150 patients with 2019 nCov infection consisted of 67 men and 83 women, and the median age was (45±16) years; 69 of them were the first generation case,60 of them were the second generation case, 6 of them were the third generation case,the median incubation period of the first generation case was (5.4±2.2) days, and the second generation case was (6.7±3.1) days, and the first-generation cases are the majority in severe patients (69%) . The most common basic disease was hypertension (13 cases, 9%), diabetes (9 cases, 6%), and the most common symptom is fever(142 cases, 95%, 63% showed moderate fever) , cough and sputum(108 cases,72%), fatigue(23 cases,15%), anorexia(20 cases, 13%), headache, diarrhea, muscle soreness, sore throat as the first symptoms. The average time from onset of symptoms to consultation was (4.2±2.2) days for all patients. The changes in peripheral blood cells were mainly lymphonpenia (83 cases, 55%) and eosinophilia (95 cases, 63%), The lymphocyte count of the severe and critically ill patients was more significantly reduced, and some patients had increased myocardial enzymes, mainly LDH (47 cases, 31%), and a few patients had liver function damage, mainly manifested in ALT and AST. High, very few patients have renal impairment. Among the inflammation-related indicators, the main manifestations are increased CRP (66 cases, 43%) and ESR (86 cases, 57%), elevated D-Dimer in 29% of patients. 144 cases have different degrees of infective lesions in chest CT examination, with 30 cases (21%) on one side and 144 cases (79%) on both sides. Morphologically, most of the lesions were patchy ground glass lesions, which could be accompanied by air bronchus signs and some consolidation and paving stone signs. Of the cases showing "white lung", 87% were sever ill or critically ill. After active treatment, 45% of patients were discharged according to discharge standards. 33% of sever and critically ill patients were discharged, 49% of them were degraded hospitalization.The average length of hospitalization was (12±4) days.
Conclusion: A history of epidemiological exposure, fever, chest CT with signs of pneumonia, normal or decreased WBC, and lymphocytopenia, eosinophilia are the clinical basis for the diagnosis of this disease, and most of the sever patients were the first generation cases. The degree of lymphocytopenia is related to the severity of the disease.

Entities:  

Keywords:  2019 Novel coronavirus; Pneumonia

Mesh:

Year:  2020        PMID: 32295322     DOI: 10.3760/cma.j.cn112147-20200224-00168

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  9 in total

1.  Central nervous system manifestations in COVID-19 patients: A systematic review and meta-analysis.

Authors:  Shahrzad Nazari; Amirhossein Azari Jafari; Seyyedmohammadsadeq Mirmoeeni; Saeid Sadeghian; Mohammad Eghbal Heidari; Siavash Sadeghian; Farhad Assarzadegan; Seyed Mahmoud Puormand; Hamid Ebadi; Davood Fathi; Sahar Dalvand
Journal:  Brain Behav       Date:  2021-01-09       Impact factor: 3.405

2.  Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19.

Authors:  Murat Seyit; Esin Avci; Rukiye Nar; Hande Senol; Atakan Yilmaz; Mert Ozen; Alten Oskay; Hulya Aybek
Journal:  Am J Emerg Med       Date:  2020-12-06       Impact factor: 2.469

3.  Impact of Ethnicity and Underlying Comorbidity on COVID-19 Inhospital Mortality: An Observational Study in Abu Dhabi, UAE.

Authors:  Asma Deeb; Khulood Khawaja; Nida Sakrani; Abdulla AlAkhras; Ahmed Al Mesabi; Ravi Trehan; Palat Chirakkara Kumar; Zahir Babiker; Nico Nagelkerke; Emmanuel Fru-Nsutebu
Journal:  Biomed Res Int       Date:  2021-03-01       Impact factor: 3.411

4.  Differential Impact of COVID-19 Risk Factors on Ethnicities in the United States.

Authors:  Prashant Athavale; Vijay Kumar; Jeremy Clark; Sumona Mondal; Shantanu Sur
Journal:  Front Public Health       Date:  2021-12-06

5.  Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 Strains: A Systematic Review and Meta-analysis.

Authors:  Yu Wu; Liangyu Kang; Zirui Guo; Jue Liu; Min Liu; Wannian Liang
Journal:  JAMA Netw Open       Date:  2022-08-01

6.  Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.

Authors:  Yanyan Wu; Hongyu Li; Xiaozhong Guo; Eric M Yoshida; Nahum Mendez-Sanchez; Giovanni Battista Levi Sandri; Rolf Teschke; Fernando Gomes Romeiro; Akash Shukla; Xingshun Qi
Journal:  Hepatol Int       Date:  2020-07-24       Impact factor: 6.047

7.  A systematic review of neurological symptoms and complications of COVID-19.

Authors:  Xiangliang Chen; Sarah Laurent; Finja Schweitzer; Clemens Warnke; Oezguer A Onur; Nina N Kleineberg; Gereon R Fink
Journal:  J Neurol       Date:  2020-07-20       Impact factor: 4.849

8.  Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19.

Authors:  Anand V Kulkarni; Pramod Kumar; Harsh Vardhan Tevethia; Madhumita Premkumar; Juan Pablo Arab; Roberto Candia; Rupjyoti Talukdar; Mithun Sharma; Xiaolong Qi; Padaki Nagaraja Rao; Duvvuru Nageshwar Reddy
Journal:  Aliment Pharmacol Ther       Date:  2020-07-08       Impact factor: 9.524

9.  Gastrointestinal symptoms and fecal nucleic acid testing of children with 2019 coronavirus disease: a systematic review and meta-analysis.

Authors:  Ji-Gan Wang; Hai-Rong Cui; Hua-Bo Tang; Xiu-Li Deng
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.